Further validation of PPARG’s effect on this pathway was established through immunoblot of tumour lysates probing for PPARG, AKT3, PGC1α, CRM1 and VDAC1 (Fig. 2K and Supplementary Fig. 2B, C). The gene discussed is PPARG; the disease is neoplasm.